27493925|t|The effect of green tea extract supplementation on sputum smear conversion and weight changes in pulmonary TB patients: A randomized controlled trial
27493925|a|Acceleration in sputum smear conversion helps faster improvement and decreased probability of the transfer of TB. In this study, we aimed to investigate the effect of green tea extract supplementation on sputum smear conversion and weight changes in smear positive pulmonary TB patients in Iran. In this double blind clinical study, TB patients were divided into intervention, (n=43) receiving 500 mg green tea extract (GTE), and control groups (n=40) receiving placebo for two months, using balanced randomization. Random allocation and allocation concealment were observed. Height and weight were measured at the beginning, and two and six months post-treatment. Evaluations were performed on three slides, using the ZiehlNeelsen method. Independent and paired t test, McNemar's, Wilcoxon, Kaplan-Meier, Cox regression model and Log-Rank test were utilized. Statistical significance was set at p<0.05. This trial was registered under IRCT201212232602N11. The interventional changes and the interactive effect of intervention on weight were not significant (p>0.05). In terms of shortening the duration of conversion, the case to control proportion showed a significant difference (p=0.032). Based on the Cox regression model, the hazard ratio of the relative risk of delay in sputum smear conversion was 3.7 (p=0.002) in the higher microbial load group compared to the placebo group and 0.54 (95% CI: 0.31-0.94) in the intervention compared to the placebo group. GTE decreases the risk of delay in sputum smear conversion, but has no effect on weight gain. Moreover, it may be used as an adjuvant therapy for faster rehabilitation for pulmonary TB patients.
27493925	4	10	effect	T080	C1280500
27493925	14	31	green tea extract	T109,T121	C1704263
27493925	32	47	supplementation	T061	C0242297
27493925	51	63	sputum smear	T059	C2019329
27493925	64	74	conversion	T061	C0444785
27493925	79	93	weight changes	T033	C0005911
27493925	97	109	pulmonary TB	T047	C0041327
27493925	110	118	patients	T101	C0030705
27493925	122	149	randomized controlled trial	T062	C0206035
27493925	150	162	Acceleration	T067	C0000894
27493925	166	178	sputum smear	T059	C2019329
27493925	179	189	conversion	T061	C0444785
27493925	196	214	faster improvement	T077	C2986411
27493925	219	228	decreased	T081	C0205216
27493925	229	240	probability	T081	C0033204
27493925	260	262	TB	T047	C0041296
27493925	272	277	study	T062	C2603343
27493925	282	287	aimed	T078	C1947946
27493925	291	302	investigate	T169	C1292732
27493925	307	313	effect	T080	C1280500
27493925	317	334	green tea extract	T109,T121	C1704263
27493925	335	350	supplementation	T061	C0242297
27493925	354	366	sputum smear	T059	C2019329
27493925	367	377	conversion	T061	C0444785
27493925	382	396	weight changes	T033	C0005911
27493925	400	414	smear positive	T033	C1335447
27493925	415	427	pulmonary TB	T047	C0041327
27493925	428	436	patients	T101	C0030705
27493925	440	444	Iran	T083	C0022065
27493925	467	481	clinical study	T062	C0008972
27493925	483	485	TB	T047	C0041296
27493925	486	494	patients	T101	C0030705
27493925	500	507	divided	T169	C0332849
27493925	513	525	intervention	T061	C0184661
27493925	534	543	receiving	T080	C1514756
27493925	551	568	green tea extract	T109,T121	C1704263
27493925	570	573	GTE	T109,T121	C1704263
27493925	580	594	control groups	T096	C0009932
27493925	602	611	receiving	T080	C1514756
27493925	612	619	placebo	T122	C1696465
27493925	624	634	two months	T079	C0439231
27493925	642	664	balanced randomization	T062	C0034656
27493925	666	683	Random allocation	T062	C0034656
27493925	688	698	allocation	T052	C1706778
27493925	699	710	concealment	T080	C0443189
27493925	716	724	observed	T169	C1441672
27493925	726	743	Height and weight	T032	C0424638
27493925	749	757	measured	T080	C0444706
27493925	765	774	beginning	T079	C0439659
27493925	792	798	months	T079	C0439231
27493925	799	813	post-treatment	T079	C2709088
27493925	815	826	Evaluations	T058	C0220825
27493925	832	841	performed	T169	C0884358
27493925	851	857	slides	T075	C0444330
27493925	869	888	ZiehlNeelsen method	T059	C1318721
27493925	890	901	Independent	T170	C0871472
27493925	906	919	paired t test	T170	C1709451
27493925	921	930	McNemar's	T170	C0282574
27493925	932	940	Wilcoxon	T170	C0871608
27493925	942	954	Kaplan-Meier	T081	C1720943
27493925	956	976	Cox regression model	T081,T170	C0010235
27493925	981	994	Log-Rank test	T170	C0282574
27493925	1000	1008	utilized	T080	C0205556
27493925	1010	1034	Statistical significance	T081	C0237881
27493925	1059	1064	trial	T062	C0008976
27493925	1069	1079	registered	T058	C1514821
27493925	1111	1125	interventional	T061	C0184661
27493925	1126	1133	changes	T169	C0392747
27493925	1142	1153	interactive	T169	C1704675
27493925	1154	1160	effect	T080	C1280500
27493925	1164	1176	intervention	T061	C0184661
27493925	1180	1186	weight	T032	C0005910
27493925	1192	1207	not significant	T033	C1273937
27493925	1230	1240	shortening	T080	C1282927
27493925	1245	1253	duration	T079	C0449238
27493925	1257	1267	conversion	T061	C0444785
27493925	1273	1299	case to control proportion	T080	C3274646
27493925	1300	1306	showed	T080	C0205556
27493925	1309	1320	significant	T078	C0750502
27493925	1321	1331	difference	T080	C1705242
27493925	1356	1376	Cox regression model	T081,T170	C0010235
27493925	1382	1394	hazard ratio	T081	C2985465
27493925	1402	1415	relative risk	T081	C0242492
27493925	1419	1424	delay	T079	C0205421
27493925	1428	1440	sputum smear	T059	C2019329
27493925	1441	1451	conversion	T061	C0444785
27493925	1477	1483	higher	T080	C0205250
27493925	1484	1498	microbial load	T081	C2936404
27493925	1499	1504	group	T098	C1257890
27493925	1505	1513	compared	T052	C1707455
27493925	1521	1528	placebo	T122	C1696465
27493925	1529	1534	group	T098	C1257890
27493925	1571	1583	intervention	T061	C0184661
27493925	1584	1592	compared	T052	C1707455
27493925	1600	1607	placebo	T122	C1696465
27493925	1608	1613	group	T098	C1257890
27493925	1615	1618	GTE	T109,T121	C1704263
27493925	1619	1628	decreases	T033	C0442797
27493925	1633	1637	risk	T078	C0035647
27493925	1641	1646	delay	T079	C0205421
27493925	1650	1662	sputum smear	T059	C2019329
27493925	1663	1673	conversion	T061	C0444785
27493925	1686	1692	effect	T080	C1280500
27493925	1696	1707	weight gain	T033	C0043094
27493925	1740	1756	adjuvant therapy	T061	C0677850
27493925	1761	1767	faster	T080	C0456962
27493925	1768	1782	rehabilitation	T169	C0034992
27493925	1787	1799	pulmonary TB	T047	C0041327
27493925	1800	1808	patients	T101	C0030705